TransMedics Group Inc (TMDX)

Exchange
NASDAQ
Symbol
TMDX
Sector
Life Sciences
Industry
Electromedical & Electrotherapeutic Apparatus
Description
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.
Country
USA

Stock price

At close: August 8, 2025

  • Open
    115.50
  • High
    118.68
  • Low
    114.30
  • Close
    114.50
  • Volume
    692,477

Financial ratios

Dec 31, 2024